Web Results

Mobile country code

en.wikipedia.org/wiki/Mobile_country_code

The ITU-T Recommendation E.212 defines mobile country codes as well as mobile network ... 2.1.1 Abkhazia - GE-AB; 2.1.2 Afghanistan - AF; 2.1.3 Albania - AL; 2.1.4 Algeria - DZ; 2.1.5 ... Guinea - G...

Modulating autophagy: a strategy for cancer therapy - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC4012266/

Since Takeshige et al. carried out the first genetic screen for autophagy mutants, ... In the presence of Hsc73 and other Hsp70 co-chaperones, such as Hsp40, Hsp90, ..... Copetti et al. demonstrated that the NF-κB family member p65/RelA (v- rel ... and it is considered the first-line treatment for advanced renal cell carcinoma ...

Alternative TEL-JAK2 fusions associated with T-cell acute ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3685286/

TEL-JAK2 fusion types derived from both T-cell acute lymphoblastic leukemia and .... After incubation at 37°C in 10% (v/v) CO2 for 2 days, a total cell lysate was ..... and Deakin University International Research Scholarship Scheme (SMNO, PR, JK). ... Flex E, Petrangeli V, Stella L, Chiaretti S, Hornakova T, Knoops L, et al .

Circulating Biomarkers in Advanced Renal Cell Carcinoma: Clinical ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3872150/

Clinical Applications for Circulating Biomarkers in Advanced RCC ..... Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. ..... Heymach JV, Shackleford TJ, Tran HT, Yoo SY, Do KA, Wergin M, et al. Effect of .... of the 100th Annual Meeting of the American Association for Cancer Research; Denver, CO.

Cell Death and Disease - Early effects of the antineoplastic agent ...

www.nature.com/cddis/journal/v6/n10/full/cddis2015263a.html

Oct 22, 2015 ... Advanced search ... Tel: +39 049 827 6324; Fax: +39 049 827 6300; E-mail: ildi@ civ.bio.unipd.it ... SAL has been proved to induce programmed cell death of cancer .... In particular, Gupta et al. showed (and we confirmed (not shown)) .... The same experiments were performed on B-CLL cells co-cultured ...

Phase 2 study of panobinostat with or without rituximab in relapsed ...

www.bloodjournal.org/content/128/2/185

Up to 40% of patients with diffuse large B-cell lymphoma (DLBCL) are not cured ... were not routinely performed except to confirm CR in patients with prolonged PR. ... Each study arm had 90% power to detect a response rate of 30% vs 5% using a ..... BCL6 expression, but this observation was not reproduced by Pon et al.

Vesicle trafficking in plant immune responses - Robatzek - 2006 ...

onlinelibrary.wiley.com/doi/10.1111/j.1462-5822.2006.00829.x/full

Oct 12, 2006 ... The first is expressed principally at the cell surface and involves perception of ... callose deposition and cell wall thickening (Chisholm et al., 2006). .... 1, LPS was co-internalized with TLR4 and its interacting partner MD2. .... for exocytosis of vesicles containing antimicrobial PR proteins in this species.

Full Text - Acta Biochimica et Biophysica Sinica - Oxford Journals

abbs.oxfordjournals.org/content/42/5/311.full

Totally, 96 patients with advanced NSCLC were routinely treated with ... Lung cancer, predominantly non-small-cell lung cancer (NSCLC), is one of the .... partial response (PR), stable disease (SD), and progressive disease (PD). ..... Olaussen KA,; Dunant A,; Fouret P,; Brambilla E,; Andrée F,; Haddad V,; Taranchon E,; et al.

THE ADVANCE OF PERSONALIZED AND STRATIFIED ... - IFCC

www.ifcc.org/media/252459/08_Renz.pdf

Telephone: +49-(0)6421-5866234 ... Recently, the heterogeneity in terms of cellular and molecular pathways .... Viral infections are co-modulators of early onset BA. Early .... marker for a TH2-driven immune-response, Woodruff et al. ... different integrin molecules on the cell surface such as alpha-V/beta1, alpha-V/ beta3 and ...

Frontiers | Hypoxia and Hypoxia-Inducible Factors in Leukemias ...

journal.frontiersin.org/article/10.3389/fonc.2016.00041/full

<sup>1</sup>Génétique, Immunothérapie, Chimie et Cancer (GICC) UMR 7292, CNRS, UFR de ..... (122) discovered a translocation involving TEL and ARNT in an AML patient .... Nombela-Arrieta C, Pivarnik G, Winkel B, Canty KJ, Mahoney JE, Park S-Y, et al. ..... Hypoxia-induced HIF-1 α accumulation is augmented in a co- culture of ...

More Info

Therapeutic targeting of cancers with loss of PTEN function - NCBI

www.ncbi.nlm.nih.gov

PI3K is a critical node in a major signaling pathway that regulates cancer cell ..... PI3K/AKT/mTOR pathway inhibitors in patients with advanced HER2+ breast cancer. ... antibody therapy for CRC, PTEN loss/mutation often co-exists with mutations .... Putz et al. found that PTEN is exported in exosomes in a Ndfip1- dependent ...

A phase II study of enzastaurin in combination with erlotinib in ...

www.sciencedirect.com

Jul 17, 2012 ... Eligible patients with advanced NSCLC (IIIB or IV) who had failed one or two .... criteria were met for complete response (CR) or partial response (PR) (whichever ... current smokers (median PFS of 10.3 vs 1.6 months, respectively; P = 0.02). .... The TAX 320 Non-Small Cell Lung Cancer Study Group, et al.

Cell Research - The RNA-binding protein Mex3B is a coreceptor of ...

www.nature.com

Jan 29, 2016 ... Correspondence: Yan-Yi Wang, Tel: +86-27-87198095; Fax: ... Advance online publication 29 January 2016 ... TLR3 is expressed in a variety of cell types, such as dendritic cells (DCs), ..... When 293 cells were co-transfected with Mex3B and TLR3, ..... Article | PubMed |; Bell JK, Botos I, Hall PR, et al.